Also from this source


24 Apr, 2017, 08:15 ET Immune Receives Nasdaq Letter

You just read:

Immune Pharmaceuticals and Hadasit File a Joint Patent on the Oral Use of Anti-Eotaxin Monoclonal Antibodies, Including Bertilimumab, for the Treatment of GI and Liver Diseases

News provided by

Immune Pharmaceuticals Inc.

07 Jun, 2016, 19:56 ET